Predictive Oncology is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.
Predictive Oncology is a publicly traded company on using the ticker symbol SKLNU.
Detailed information on company financials and operating reports can be found here:
: SKLNU
Predictive Oncology Annual Revenue and Growth Rate
Note: Predictive Oncology's revenues are gauged from an analysis of company filings.
Investor Activity
Predictive Oncology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
June 2, 2022
4
100%
$2 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Predictive Oncology is developing and marketing.
Predictive Oncology doesn't have any recent trademark applications, indicating Predictive Oncology is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
PORTALAI Software as a service, namely, an artificial intelligence based searchable bioinformatics platform for use in genomic and drug response therapy
01/09/2020
PO Testing samples of cancer cells to develop customized medical treatments
12/31/2019
DEVITAONE Medical research, testing samples of cancer cells to develop customized medical treatments
06/04/2019
See all trademarks and details in the Full Report.
Market Share of Predictive Oncology's Largest Competitors
A competitive analysis shows these companies are in the same general field as Predictive Oncology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Predictive Oncology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Predictive Oncology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.